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The objective of the present study was to describe two non-invasive methods for fat quantification in normal canine liver by using magnetic 
resonance imaging (MRI) and spectroscopy. Eleven adult beagle dogs were anesthetized and underwent magnetic resonance examination of 
the cranial abdomen by performing morphologic, modified Dixon (mDixon) dual gradient echo sequence, and proton magnetic resonance 
spectroscopy (1H MRS) imaging. In addition, ultrasonographic liver examination was performed, fine-needle liver aspirates and liver biopsies 
were obtained, and hepatic triglyceride content was assayed. Ultrasonographic, cytologic, and histologic examination results were 
unremarkable in all cases. The median hepatic fat fraction calculated was 2.1% (range, 1.3%–5.5%) using mDixon, 0.3% (range, 0.1%–1.0%) 
using 1H MRS, and 1.6% (range 1.0%–2.5%) based on triglyceride content. The hepatic fat fractions calculated using mDixon and 1H MRS 
imaging were highly correlated to that based on triglyceride content. A weak correlation between mDixon and 1H MRS imaging was detected. 
The results show that hepatic fat content can be estimated using non-invasive techniques (mDixon or 1H MRS) in healthy dogs. Further studies 
are warranted to evaluate the use of these techniques in dogs with varying hepatic fat content and different hepatic disorders.
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Introduction
Intracellular fat accumulation in the liver is a common feature 
of many liver disorders, and hepatic steatosis is widely 
recognized in humans as the most prevalent cause of liver 
disease and a contributing factor in the progression of chronic 
hepatic disorders [18,28]. Hepatic steatosis (lipidosis) is also 
observed in dogs and cats and is associated with obesity, 
diabetes, prolonged fasting, congenital portosystemic shunts, 
endocrinopathy, and toxic liver injury [4]. Consequently, 
diagnostic tools to reliably detect and grade hepatic fat 
accumulation have been much sought after in human medicine 
and may prove useful in veterinary medicine [33]. Liver biopsy, 
the current gold standard, is invasive, provides evaluation of 
only 0.002% of the liver, is subject to inter-observer variability, 
and is associated with a risk of bleeding [2,18]. Ultrasound can 
detect moderate to marked fatty infiltration of the liver but other 
diffuse hepatic disorders may have similar sonographic 
appearances, and interpretation is operator-dependent [6,8,9, 
13,16]. Moreover, quantitative methods based on histogram 
analysis only grade echogenicity, which is non-specific for fatty 
infiltration, and inapplicable in routine practice [5,8]. Computed 
tomography has been evaluated in humans and cats for the 
diagnosis of hepatic lipidosis but is unreliable at quantifying 
fatty infiltration when concurrent hepatic parenchymal disease 
exists [14,21].
Dual gradient echo magnetic resonance imaging (DGE-MRI) 
is considered one of the most sensitive modalities for the 
detection of fatty infiltration of the liver in humans [2]. This 
technique uses chemical shift imaging, taking advantage of the 
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different precession frequencies of fat and water protons in a 
magnetic field. Different echo-time parameters are used such 
that the signal from fat protons is either in phase (IP) or in 
opposed phase (OP) with that of water protons. The derived 
signals are those of fat and water added together (IP) or water 
minus fat signal (OP) [20]. Using this principle, the modified 
Dixon (mDixon) imaging method uses a reconstruction algorithm 
from which the fat fraction is derived from the difference in IP 
and OP signal intensities on a pixel-by-pixel basis, producing 
water only, fat only, IP, and OP images via fast gradient echo 
sequencing [18].
Proton magnetic resonance spectroscopy (1H MRS) records 
signals from protons embedded in different chemical bonds 
within a given volume of tissue, with the bonds identified by 
their spectral frequencies. As protons are surrounded by nuclei 
and electrons with their own magnetic properties, slight differences 
occur in the received frequencies from protons in different 
chemical bonds. The spectral position of resonances, due to 
these chemical shifts, is expressed in parts per million (ppm) 
relative to a reference set at 0 ppm. At field strengths at or above 
1.5 T, the frequency peaks of lipid and water protons are 
approximately 1.2 ppm and 4.7 ppm, respectively [18].
As 1H MRS can distinguish spectral frequencies of protons in 
water from those in fatty acids, the fat signal fraction can be 
calculated, providing an accurate measure of hepatic fat 
compared to estimates from biopsy or chemical triglyceride 
assays [3,18,29]. Previous studies have described hepatic fat 
quantification using 1H MRS in humans [18], lean and obese 
cats [3], and rats [26], as well as in a study of experimentally- 
induced hepatic fat accumulation in dogs and rabbits [29]. In 
lean and obese cats, the median liver fat percentages measured 
by applying 1H MRS were 1.3% and 6.8%, respectively [3]. To 
the authors’ knowledge, hepatic fat content in lean or obese 
dogs has not, thus far, been quantified by using DGE-MRI or 1H 
MRS techniques.
The objective of this prospective sample survey study was to 
explore the feasibility of hepatic fat quantification by using 
DGE-MRI and 1H MRS in healthy adult dogs and to compare fat 
quantification derived via these techniques with results from 
histological and cytological examination, which represent the 
standard diagnostic approach in clinical patients. The use of the 
investigated techniques in a clinical setting may be of potential 
benefit in non-invasive diagnosis and monitoring of canine 
patients.
Materials and Methods
Ethical approval
All procedures involving the dogs in this study were approved 
by the Cantonal Veterinary Office of Zurich (approval No. 
114/2013).
Dogs
Eleven research purpose-bred dogs (5 females and 6 males) 
were used in the study. The dogs had a mean age of 4.1 years 
(range, 3.4–6 years) and a mean body weight of 13.6 kg (range, 
10.0–15.0 kg). The dogs had a median body condition score 
(BCS) of 7/9 (range, 6–8). The dogs were deemed healthy based 
on physical examination, complete blood count, and 
biochemistry profile results.
Anesthesia
Dogs were anesthetized following a standard protocol. This 
included premedication with methadone (0.2 mg/kg) followed, 
30 min later, by midazolam (0.1 mg/kg intravenous [IV]) 
administered via a cephalic catheter. Anesthesia was induced, 
to effect, with propofol. Following endotracheal intubation, 
anesthesia was maintained by using sevoflurane delivered in an 
oxygen/air mixture with a flow of 50 mL/kg/min and an inspired 
fraction of oxygen of 0.5. Dogs were mechanically ventilated 
by using a breathing system in volume-cycled mode to maintain 
an end-tidal PCO2 of 35 mmHg. Lactated Ringer’s solution (5 
mL/kg/h) was administered IV throughout anesthesia. Monitoring 
included continuous assessment of heart and respiratory rates, 
pulse oximetry, body temperature, and end-tidal PCO2, as well 
as intermittent oscillometric non-invasive blood pressure 
measurements. If mean arterial pressure was below 60 mmHg, 
the inspired fraction of sevoflurane was decreased by 0.5% and 
an IV fluid bolus (2 mL/kg) of lactated Ringer’s solution was 
administered. If hypotension persisted, a constant rate infusion 
of IV dobutamine (initial dose, 2 g/kg/h) was administered.
Magnetic resonance imaging and spectroscopy
The dogs were placed in dorsal recumbency in a 3 T scanner 
(Philips Ingenia 3.0 T scanner; Philips Healthcare, Switzerland) 
with a phased-array anterior coil (dStream body coil solution, 
32 channels; Philips Healthcare). Initial transverse cranial 
abdominal sequences were performed to rule out hepatic 
morphologic abnormalities by obtaining T2-weighted (turbo 
spin echo; repetition time, 1,250 msec; echo time, 80 msec; flip 
angle, 90o; field of view, 220 mm; voxel size, 0.60 mm × 0.73 
mm × 3.00 mm; slice thickness, 3.00 mm; slice gap, 0.5 mm) 
and T1-weighted pre- and post-contrast scans.
For breath-hold sequences (both DGE-MRI and 1H MRS 
sequences), mechanical ventilation was interrupted to allow 
brief expiratory apnea (maximal scan length, 28 sec) and 
resumed immediately thereafter. The DGE-MRI sequence was 
performed on the cranial abdomen via a transverse scan (3D 
T1-weighted, fast dual gradient echo; repetition time, 3.6 msec; 
echo times, 1.2 msec [OP] and 2.3 msec [IP]; field of view, 280 
mm × 280 mm × 165 mm; voxel size, 1.5 mm × 2.5 mm × 1.5 
mm; number of excitations, 1). Hepatic 1H MRS spectra were 
obtained by using a multi-echo single shot technique (point 
resolved spectroscopy, PRESS) on a single voxel (volume, 20 
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Fig. 1. Representative example of the appearance of a normal 
liver in the in-phase (A) and opposed-phase (B) imaging from 
dual gradient echo magnetic resonance imaging sequences. A 
regions of interest drawn in the left caudal parenchyma is shown
(circles). The signal intensity is similar on both images and the 
mean calculated hepatic fat fraction was 1.1%.
mm3) of the liver (echo time, 38 msec; recovery time, 2,000 
msec; number of signal averages, 12; spectral bandwidth, 2,000 
Hz; flip angle, 90o) using pencil-beam automatic shimming. 
The voxel to be analyzed was selected based on the T2-weighted 
and DGE-MRI sequences in order to avoid blood vessels, 
gallbladder, and fatty tissue.
Finally, gadodiamide contrast (Gadodiamid [Omniscan], 0.3 
mmol/kg; GE Healthcare, Switzerland) was administered IV by 
using an automatic injector (2 mL/sec), followed by a 10 mL 
saline flush. An enhanced T1 high-resolution isotropic volume 
excitation (e-Thrive) sequence was performed by using turbo 
field echo, and SENSE (dynamic parallel imaging performance 
sensitivity) encoding was performed (repetition time, 3.1 msec; 
echo time, 1.5 msec; flip angle, 10o; field of view, 280 mm; 
voxel size, 1.49 mm × 1.51 mm × 3.00 mm; slice thickness, 3 
mm; slice gap, –1.5 mm; number of dynamics, 6). The scan was 
manually started when contrast enhancement was visible in the 
descending aorta in the pre-monitoring window and was 
repeated 6 times consecutively.
Ultrasound and tissue sampling
Following the MRI and spectroscopy procedures, and during 
the same anesthesia session, dog livers were examined by using 
ultrasound (Philips iU22 Ultrasound system; Philips 
Healthcare) applied by a single examiner (F. Del Chicca). Two 
ultrasound-guided fine-needle (22 gauge) aspirates and two 
ultrasound-guided needle biopsies (Tru-cut, 16 gauge) using an 
automatic biopsy gun were obtained.
Subsequently, the dogs recovered from anesthesia following 
IV methadone (0.2 mg/kg) administration and were monitored 
for 2 to 4 h in the intensive care unit. Finally, a follow-up 
abdominal ultrasound was performed to evaluate the abdomen 
for possible signs of a bleeding complication.
Tissue processing analysis
All cytologic and histologic samples were assessed by a 
single board-certified pathologist (P. Grest) blinded to the 
imaging outcomes. Cytologic samples were stained with a 
modified Wright’s stain. Biopsies from 7 of the 11 dogs were 
fixed in 4% buffered formaldehyde and embedded in paraffin. 
Sections (4 m thick) were cut and routinely stained with 
hematoxylin and eosin. In formalin-fixed, paraffin-embedded 
tissue, fat presents as velar, empty, variable-sized vacuoles. 
Hepatocytes were evaluated for the presence of microvesicular 
changes characterized by numerous uniform intracytoplasmic 
vacuoles that are smaller than the centrally located nucleus or 
for macrovesicular changes with vacuoles the size of the 
nucleus or larger and, frequently, with a displaced nucleus. 
Biopsies from the remaining 4 dogs were used for the 
biochemical assays. This was done by extracting lipids by 
applying a modified Foch method. Briefly, 1 mL 
chloroform/methanol (2:1) was added to 50 mg fresh liver 
followed by homogenizing in a bead mill (30 Hz, 4 × 30 sec). 
The homogenate was centrifuged (5 min) to separate the upper 
phase (aqueous methanol dragging) and lower phase (chloroform) 
containing lipids. The upper phase was removed by siphoning, 
which was repeated after rinsing the interface between phases 
twice with methanol/water (1:1) without mixing. The lower 
chloroform phase was evaporated under vacuum, resuspended 
in 50 L DMSO, and shaken for 20 min at 37oC. Finally, 
triglyceride level was measured by using a commercial enzymatic 
colorimetric kit (Diatools Trig; Diatools, Switzerland) on a 
biochemistry analyzer (Cobas Mira; Roche Diagnostics, 
Switzerland).
Postprocessing and data analysis
Postprocessing of magnetic resonance data was conducted on 
a dedicated workstation (Extended MR WorkSpace, ver. 2.6.3.5; 
Philips Medical Systems, The Netherlands).
On DGE-MRI sequences, 3 regions of interest (ROIs) that 
avoided large vessels and organ boundaries were drawn in the 
liver parenchyma (Fig. 1). The signal intensity (SI) in IP and OP 
phase images was recorded and the hepatic fat fraction (HFF) 
was calculated as [SI(IP) – SI(OP)] / [2 × SI(IP)] [18]. For data 
analysis, the average of 3 calculated HFF values was used.
The relative proton densities of fat and water were calculated 
from 1H MRS spectral data by using an automated fitting 
method (LCModel, ver. 6.3-0B; Stephen Provencher, Canada) 
[23]. The fitting algorithm for liver analysis provided estimates 
for all lipid signals. For hepatic fat quantification, the ratio 
between the fat signal peaks and the sum of the fat and water 
peaks was calculated [fat signal peak / (fat signal peak area + 
water peak area)] (Fig. 2). The ratio was corrected for different 
T1 times of water and fat in relation to the applied repetition 
time (2,000 msec).
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Fig. 2. Representative proton magnetic resonance spectroscopy
spectrum of the dog from Fig. 1 showing the corresponding 
transverse (left image), sagittal (middle image) and dorsal (right 
image) localizing scans and the voxel placement (red polygon). 
On the graph, the x-axis indicates the chemical shift in parts per
million (ppm). The highest peak, at the 4.6 ppm position, 
corresponds to the water peak. The smaller peak at the 1.2 ppm,
corresponds to the lipid peak. The calculated hepatic fat fraction
was 0.63%.
Fig. 3. Box plots of hepatic fat fraction (HFF) measured by using 
dual gradient echo magnetic resonance imaging (modified 
Dixon), proton magnetic resonance spectroscopy (MRS), and 
biochemical analysis (Bioc). 
Statistical analysis
Statistical analysis was performed by using a commercial 
software package (IBM SPSS Statistics for Windows, ver. 21.0, 
64-bit edition; IBM, USA). Descriptive statistics were obtained 
and hepatic triglyceride concentration results from biochemical 
analysis and HFF, calculated with DGE-MRI and 1H MRS, 
were compared. Correlation between measurements was assessed 
by using Spearman’s rank correlation with significance set at 
p ＜ 0.01. For interpretation of the strength of an association, 
rank correlation (rs) values of 0.8 to 1.0 were regarded as very 
strong, 0.6 to 0.79 as strong, 0.4 to 0.59 as moderate, 0.2 to 0.39 
as weak, and 0 to 0.19 as very weak.
Results
The results of ultrasonographic examinations of liver and 
gallbladder were considered unremarkable in echogenicity and 
structures in all dogs. Likewise, cytologic and H&E stained 
histologic samples revealed no abnormalities or intracytoplasmic 
lipid vacuoles in any of the dogs. Histologic samples stained 
with Oil Red O revealed small (＜ 1 m) lipid droplets within 
hepatocytes and bile ducts. Hepatic MRI morphology was 
considered unremarkable with homogeneous hyperintense 
signals compared to the epaxial musculature and hypointense 
signals compared to the spleen on T2-weighted images, as well 
as homogeneous and mildly hyperintense signals compared to 
the epaxial musculature on T1-weighted mages. The mean 
length of the T2-weighted sequences was 6.2 2.9 min, while 
that of DGE-MRI sequences was of 2 min 30 sec. The mean 
length of the spectroscopy sequences was 12 5 min.
The mean ± SD size of the ROIs on DGE-MRI sequences was 
1.05 ± 0.04 cm2 (Fig. 1). There was no statistically significant 
difference in HFF calculated from the different ROIs. The 
median calculated HFF was 2.1% (range, 1.3–5.5%) based on 
DGE-MRI (modified Dixon) sequences, 0.3% (range, 0.1–
1.0%) based on 1H MRS, and 1.6% (range, 1.0–2.5%) based on 
biochemical analysis (Fig. 3). The correlations between the 
biochemical analysis and HFF results based on DGE-MRI (rs = 
1.0) and 1H MRS (rs = 0.8) were very strong. However, the 
correlation between the HFFs based on DGE-MRI and 1H MRS 
analysis was weak (rs = 0.34).
Discussion
The present study evaluated two imaging techniques to 
quantify HFF in dogs and to determine their potential as 
alternative methods to invasive procedures for the diagnosis, 
grading, and/or monitoring of hepatic steatosis. To the authors’ 
knowledge, non-invasive techniques for hepatic fat quantification 
in healthy dogs have not been previously described.
A suspicion of hepatic steatosis may be aroused by observation 
of diffusely increased echogenicity when using ultrasound. 
However, increased echogenicity is not specific for fatty 
infiltration and has been described in association with a number 
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of other parenchymal disorders [9,12]. Therefore, a definitive 
diagnosis is generally only possible by sampling hepatic tissue, 
but such sampling is invasive, carries a risk of bleeding, and 
only allows evaluation of small amount of tissue. Moreover, the 
distribution of the steatosis may be uneven throughout the liver, 
and the region sampled may not be representative of the severity 
of the disease.
In humans, HFF using DGE-MRI or 1H MRS has been shown 
to have greater correlation with histopathologic examination 
results than those from ultrasound or computed tomographic 
examination [15,28,31]. In healthy humans, the HFF using 1H 
MRS was reported to be 1.9%, and a cut off of 5.6% has been 
proposed for the diagnosis of hepatic steatosis [30]. Other 
studies have shown that DGE-MRI yields HFF values comparable 
to quantitative fat measurements from biopsies [11,19] and 1H 
MRS measurements [1,10]. Moreover, one study showed that 
HFF based on DGE-MRI was the most accurate method for the 
diagnosis of hepatic steatosis compared to results from other 
non-invasive imaging techniques [15].
On morphological MRI images the liver of all dogs was 
considered to have normal signal intensity [7]. Data from the 
present study suggest that DGE-MRI is also valid for estimation 
of HFF in canine livers as it provided a high correlation with the 
biochemical fat quantification estimates. Given that DGE-MRI 
is fast, it is relatively insensitive to motion artifacts and requires 
only a short apnea. Moreover, it allows evaluation of images 
from the entire parenchyma, reducing the risk of 
unrepresentative sampling due to variation in the distribution of 
histopathologic lesions [13]. SI loss on IP images may, 
however, result from excessive hepatic iron accumulation [32], 
which was excluded in dogs in the present study based on 
histopathologic examinations. As all dogs in the present study 
were healthy animals, further studies are required to assess the 
usefulness of DGE-MRI and 1H MRS in dogs with hepatic 
disease.
In humans, 1H MRS was reported to have a high correlation 
(rs = 0.876) with hepatic lipid content [25,27] in non-alcoholic 
fatty liver disease. Data from the present study shows a strong 
correlation between 1H MRS and biochemical analysis results, 
similar to that reported in humans [25]. However, HFF based on 
1H MRS underestimated HFF in the present study, as was also 
previously observed in a study in mice with moderately 
elevated hepatic fat content [26].
Previous studies have shown a greater correlation between 
HFF based on 1H MRS and histology in rats with severe steatosis 
than that in those with only moderate steatosis [17] suggesting 
an increase in correlation with increasing fat content. As a 
consequence, 1H MRS may perform better when estimating 
HFF than the data from our study in healthy lean dogs suggest. 
The PRESS sequence was used in the present study, which has 
a higher signal-to-noise ratio than other spectroscopy sequences 
[22,24], although it allows measurements of only 2 of a possible 
6 lipids resonance peaks. As one of the minor lipid peaks 
overlaps with the water peak [22], and cannot be quantified with 
the PRESS sequence, this may have produced some degree of 
underestimation of HFF with 1H MRS in the present study.
Disadvantages of 1H MRS include high sensitivity to motion 
artifacts, thus a breath holding or gating technique is mandatory. 
The highly variable length of this sequence in each dog 
depended on the compensation time between subsequent apneas. 
With another kind of triggering, such as gating, it is likely that 
the sequence length would have been shorter and more uniform 
among the dogs.
In 1H MRS sequences only a small region of hepatic 
parenchyma is evaluated. The technique provides spectra for a 
small sub-region of the liver parenchyma and, in order to obtain 
a spectrum of good quality, the voxel should not be in contact 
with organ boundaries, blood vessels, or biliary structures. 
Thus, mainly in smaller dogs, there may be only limited 
possibilities for voxel placement, and the voxel may not 
necessarily match the region with the most severe pathology. In 
the dogs we examined, even if the major hepatic vessels were 
avoided, the voxel may have likely included smaller blood 
vessels. As the placement of the voxel was based on previous 
MRI sequences acquired some minutes earlier, slight motion of 
the diaphragm may have caused some degree of spatial 
mismatch. This may, at least in part, explain the weak 
correlation found between the HFFs estimated using DGE-MRI 
and 1H MRS.
Neither of the two imaging techniques used in the present 
study can be used to discriminate between microvesicular and 
macrovesicular hepatic steatosis or to show the histologic 
distribution of lipid accumulation, but both may provide 
non-invasive anatomic and semi-quantitative information 
without the use of ionizing radiation or the need for contrast 
media. Moreover, both of the described techniques require 
adequate software. For the 1H MRS, additional LCModel 
software and expertise in this field are necessary for the correct 
post-processing and data interpretation.
In contrast to human medicine, veterinary medicine MRI 
examination requires general anesthesia. This may encounter 
some clinical resistance because of the intrinsic risk for the 
patient, as well as time and costs issues. On the other hand, the 
possibility of non-invasive diagnosis and monitoring of patients 
is attractive and should be investigated.
One major limitation of the present study was the small 
number of animals examined. This greatly limits the validity of 
the measured correlations; thus, further studies are necessary to 
evaluate the use of these techniques in dogs with varying degree 
of hepatic lipid accumulation. A further limitation was that the 
region of liver sampled for biopsy was differed among the dogs 
and did not correspond to the ROI of the DGE-MRI images or 
to the voxel of the 1H MRS. As dogs included in the present 
study were lean healthy dogs with minimal hepatic fat, as 
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measured by using any technique, this is unlikely to have 
greatly affected the results, but it may be a confounder in future 
studies of dogs with hepatic disorders exhibiting non-uniform 
distribution of fat accumulation.
In conclusion, herein, we report the first use of DGE-MRI and 
1H MRS to estimate HFF in dogs. Unremarkable cytologic and 
histologic sample results in dogs with a mean BCS of 7/9 
corresponded with the reported HFF values obtained using the 
two described techniques. There was a tendency for 1H MRS to 
underestimate HFF. Further studies in dogs in different body 
condition and with varying hepatic lipid content are necessary 
for further evaluation and validation of both techniques and for 
consideration as future diagnostic applications.
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